Sight Sciences, Inc.
General ticker "SGHT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $263.3M (TTM average)
Sight Sciences, Inc. follows the US Stock Market performance with the rate: 27.8%.
Estimated limits based on current volatility of 2.9%: low 5.01$, high 5.32$
Factors to consider:
- Total employees count: 186 (-13.9%) as of 2025
- Top business risk factors: Early stage losses, Reimbursement risks, Clinical trial failure, Regulatory and compliance, Capital raising
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.05$, 12.52$]
- 2026-12-31 to 2027-12-31 estimated range: [3.76$, 9.59$]
Financial Metrics affecting the SGHT estimates:
- Positive: with PPE of -11.2 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.05 > -0.60
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: Interest expense per share per price, % of 1.17 <= 3.34
- Positive: 42.57 < Shareholder equity ratio, % of 55.46 <= 64.23
Short-term SGHT quotes
Long-term SGHT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $81.06MM | $79.87MM | $77.36MM |
| Operating Expenses | $138.33MM | $130.40MM | $114.46MM |
| Operating Income | $-57.27MM | $-50.53MM | $-37.10MM |
| Non-Operating Income | $1.84MM | $-0.74MM | $-1.32MM |
| Interest Expense | $5.41MM | $4.66MM | $5.14MM |
| R&D Expense | $17.56MM | $17.99MM | $14.61MM |
| Income(Loss) | $-55.44MM | $-51.27MM | $-38.42MM |
| Taxes | $0.11MM | $0.24MM | $0.01MM |
| Net Income(Loss)* | $-55.55MM | $-51.51MM | $-38.43MM |
| Stockholders Equity | $120.22MM | $87.52MM | $63.94MM |
| Inventory | $7.85MM | $6.33MM | $7.77MM |
| Assets | $166.65MM | $142.84MM | $115.30MM |
| Operating Cash Flow | $-47.18MM | $-22.35MM | $-29.69MM |
| Capital expenditure | $0.79MM | $0.39MM | $0.22MM |
| Investing Cash Flow | $-0.79MM | $-0.39MM | $-0.22MM |
| Financing Cash Flow | $1.10MM | $4.96MM | $1.79MM |
| Earnings Per Share** | $-1.14 | $-1.03 | $-0.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.